Outcomes of mitral valve re-replacement for bioprosthetic structural valve deterioration

被引:15
|
作者
Javadikasgari, Hoda [1 ]
Chemtob, Raphaelle A. [1 ]
Gillinov, A. Marc [1 ]
Pettersson, Gosta B. [1 ]
Lowry, Ashley M. [3 ]
Desai, Milind Y. [2 ]
Svensson, Lars G. [1 ]
Blackstone, Eugene H. [1 ,3 ]
Wierup, Per [1 ]
机构
[1] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Heart Vasc & Thorac Inst, 9500 Euclid Ave,Desk J4-1, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Cardiovasc Med, Heart Vasc & Thorac Inst, Cleveland, OH 44195 USA
[3] Cleveland Clin, Dept Quantitat Hlth Sci, Res Inst, Cleveland, OH 44195 USA
来源
关键词
heart valve replacement; outcomes research; causes of death; survival; RISK-FACTORS; SURGERY; IMPLANTATION; SOCIETY; GUIDELINES; EXPERIENCE; GRADIENT;
D O I
10.1016/j.jtcvs.2020.08.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Reoperation for structural valve deterioration (SVD) of bioprosthetic mitral valves carries a presumed high operative risk, and transcatheter mitral valve-in-valve implantation has emerged as an alternative. However, surgical risk and long-term outcome following mitral valve re-replacement in these patients remain ill-defined. Hence, we sought to evaluate outcomes and long-term survival following surgical mitral valve re-replacement and to identify risk factors for mortality. Methods: From January 1990 to January 2017, 525 patients underwent surgical mitral valve re-replacement at Cleveland Clinic for bioprosthetic SVD: 133 (25%) isolated operations and 392 (75%) with concomitant procedures. Surgical complications and modes of death were compiled, long-term mortality assessed, and risk factors identified using a multivariable nonproportional hazards model and random forest analysis. Results: SVD was characterized by bioprosthetic regurgitation in 81% (425 out of 525) and stenosis in 44%(231 out of 525). One in-hospital death occurred after isolated valve re-replacement (0.75%) and 28 deaths occurred (7.1%; P =.003) after nonisolated re-replacement, 19 (68%) of which were from coagulopathy, vasoplegia, and multisystem organ failure. In the nonisolated group, incremental risk factors for time-related death after re-replacement included New York Heart Association functional class IV symptoms, concomitant coronary artery bypass grafting, prolonged cardiopulmonary bypass time, and transfusions. Conclusions: Mitral valve re-replacement for bioprosthetic SVD was associated with low surgical risk and excellent long-term survival. Isolated mitral valve re-replacement for bioprosthetic SVD had near-zero surgical risk. Excessive cardiopulmonary bypass duration and multiple transfusions correlated with increased early mortality in nonisolated procedures, as did preoperative severe heart failure. Optimal surgical plan and timing of surgery are keys to success.
引用
收藏
页码:1804 / +
页数:14
相关论文
共 50 条
  • [21] Trans Catheter mitral Valve in Valve Replacement in a Severely Degenerated Bioprosthetic Valve
    Donepudi, Bhishma Chowdary
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (15) : S405 - S407
  • [22] Structural Valve Deterioration of Porcine Bioprosthesis Soon after Mitral Valve Repair and Replacement
    Takano, Tamaki
    Seto, Tatsuichiro
    Asaka, Shiho
    Terasaki, Takamitsu
    Ohashi, Noburou
    Fukui, Daisuke
    Amano, Jun
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 20 : 717 - 719
  • [23] Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement
    Salaun, Erwan
    Mahjoub, Haifa
    Girerd, Nicolas
    Dagenais, Francois
    Voisine, Pierre
    Mohammadi, Siamak
    Yanagawa, Bobby
    Kalavrouziotis, Dimitri
    Juni, Peter
    Verma, Subodh
    Puri, Rishi
    Cote, Nancy
    Rodes-Cabau, Josep
    Mathieu, Patrick
    Clavel, Marie-Annick
    Pibarot, Philippe
    CIRCULATION, 2018, 138 (10) : 971 - 985
  • [24] Bioprosthetic valve replacement in idiopathic hypereosinophilic syndrome with mitral valve involvement
    Fang, Qin
    Gu, Tian-Xiang
    Xiu, Zong-Yi
    Zhang, Zhi-Wei
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (05): : E45 - E47
  • [25] Postoperative Warfarin Following Mitral Valve Repair or Bioprosthetic Valve Replacement
    Thourani, Vinod H.
    Gunter, Rebecca L.
    Hurst, Stuart
    Kilgo, Patrick
    Padala, Murali
    Puskas, John D.
    Lattouf, Omar M.
    Halkos, Michael E.
    Guyton, Robert A.
    JOURNAL OF HEART VALVE DISEASE, 2013, 22 (05): : 716 - 723
  • [26] Early re-replacement after mitral valve replacement using the chimney technique in a child: a case report
    Maeda, Toshi
    Nagato, Hisao
    Ishihara, Haruko
    CARDIOLOGY IN THE YOUNG, 2023, 33 (08) : 1442 - 1444
  • [27] RIGHT THORACOTOMY, FEMOROFEMORAL BYPASS, AND DEEP HYPOTHERMIA FOR RE-REPLACEMENT OF THE MITRAL-VALVE
    COHN, LH
    PEIGH, PS
    SELL, J
    DISESA, VJ
    ANNALS OF THORACIC SURGERY, 1989, 48 (01): : 69 - 71
  • [28] Meta-Analysis Comparing Valve-in-Valve Transcatheter Mitral Valve Replacement Versus Redo Surgical Mitral Valve Replacement in Degenerated Bioprosthetic Mitral Valve
    Ismayl, Mahmoud
    Abbasi, Muhannad Aboud
    Mostafa, Mostafa Reda
    Aboeata, Ahmed
    Vora, Amit N.
    Ben-Dor, Itsik
    Anavekar, Nandan S.
    Goldsweig, Andrew M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 189 : 98 - 107
  • [29] Meta-Analysis Comparing Valve-in-Valve Transcatheter Mitral Valve Replacement Versus Redo Surgical Mitral Valve Replacement in Degenerated Bioprosthetic Mitral Valve
    Ismayl, Mahmoud
    Abbasi, Muhannad Aboud
    Mostafa, Mostafa Reda
    Aboeata, Ahmed
    Vora, Amit N.
    Ben-Dor, Itsik
    Anavekar, Nandan S.
    Goldsweig, Andrew M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 189 : 98 - 107
  • [30] Factors affecting re-replacement of the pulmonary valve in children
    Ghaffar, S
    Imamura, M
    Drummond-Webb, J
    Parker, J
    Vandevanter, S
    Morrow, WR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 385A - 385A